Company profile
BerGenBio company profile
BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers.
Business identity
- Website
- http://www.bergenbio.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0+
- Founded
- 2007-01-01, Year
Headquarters
- Headquarters
- Bergen, Vestland, Norway
- Postal code
- 5009
- Country code
- NO
- Continent
- Europe